Toyama, Japan

Kyoko Hongo

This inventor holds 1 USPTO granted patent. Top assignee: Toyama Chemical Co., Ltd.. Active years: 1978.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyoko Hongo: Innovator in Pharmaceutical Chemistry

Introduction

Kyoko Hongo is a distinguished inventor based in Toyama, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address inflammation and pain in mammals.

Latest Patents

Kyoko Hongo holds a patent for a novel alkanoic acid, specifically a 2-[4-(3-oxo- or hydroxy-alkyl)phenyl]alkanoic acid and its non-toxic salt. This patent, which is aimed at treating symptoms of inflammation and pain, outlines a process for producing these compounds and includes a pharmaceutical composition containing them. The innovative nature of her work lies in its potential applications for improving health outcomes in humans and other mammals.

Career Highlights

Hongo is currently associated with Toyama Chemical Co., Ltd., where she continues to advance her research and development efforts. Her work has garnered attention for its practical applications in medicine, showcasing her commitment to enhancing therapeutic options for patients.

Collaborations

Kyoko Hongo collaborates with notable colleagues, including Koji Miura and Kenjun Takeshima. These partnerships reflect her engagement with other experts in the field, contributing to the advancement of pharmaceutical innovations.

Conclusion

Kyoko Hongo's contributions to pharmaceutical chemistry, particularly through her patented innovations, highlight her role as a key figure in the development of effective treatments for inflammation and pain. Her work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…